STOCK TITAN
  1. Home
  2. Sec-filings
  3. SCPH
  4. [EFFECT] scPharmaceuticals Inc. SEC Filing

[EFFECT] scPharmaceuticals Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 19, 2025
Accession Number: 0001193125-25-233440
Submission Type: POS AM
CIK: 0001604950
Company Name: scPharmaceuticals Inc.
File Number: 333-229120

Source: View Original Filing on SEC EDGAR

Stock SCPH logo
Scpharmaceutical

NASDAQ:SCPH

SCPH Rankings

#4024 Ranked by Market Cap
N/A Ranked by Dividends

SCPH Latest News

Oct 7, 2025
MannKind Completes Acquisition of scPharmaceuticals, Accelerating Revenue Growth in Cardiometabolic Care
Aug 25, 2025
MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases
Aug 14, 2025
scPharmaceuticals Receives Notice of Allowances of Multiple US Patent Applications Covering SCP-111
Aug 7, 2025
scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update
Jul 31, 2025
scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025

SCPH Latest SEC Filings

Nov 20, 2025
[EFFECT] scPharmaceuticals Inc. SEC Filing
Nov 20, 2025
[EFFECT] scPharmaceuticals Inc. SEC Filing
Oct 8, 2025
[SCHEDULE 13G/A] scPharmaceuticals Inc. SEC Filing
Oct 7, 2025
[Form 4] scPharmaceuticals Inc. Insider Trading Activity
Oct 7, 2025
[Form 4] scPharmaceuticals Inc. Insider Trading Activity

SCPH Stock Data

304.36M
40.95M
5.98%
80.33%
1.29%
Biotechnology
Pharmaceutical Preparations
Link
United States
BURLINGTON